Navigation Links
OneTouch(R) Ping(TM) Glucose Management System Cleared by FDA
Date:7/1/2008

Animas Announces Clearance of Uniquely Integrated Meter/Pump System with

Remote Insulin Delivery Capabilities and Compatible Software

WEST CHESTER, Pa., July 1 /PRNewswire/ -- Animas Corporation announced today the clearance of its OneTouch(R) Ping(TM) Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

"OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing," said Juan Frias, M.D., Chief Medical Officer and Vice President of Medical Affairs, Animas Corporation. "People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier."

OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson, Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch(R) Ultra(R) Test Strips.

OneTouch Ping also offers the following:

-- Lifestyle-focused pump performance - the pump can be clipped to a belt, tucked in a pocket, or secured under clothing, is waterproof up to 12 feet for 24 hours and has a color screen for outstanding pump readability

-- Individualized control - delivers lowest basal increments (0.025 U/hr) and lowest bolus increments (0.05 U) available to more precisely match patient insulin needs

-- Proven blood glucose monitoring technology - the meter-remote utilizes OneTouch Ultra Test Strips, the leading brand of test strips covered by more health plans at the lowest co-pay

ezManager(R) MAX Diabetes Management Software

The OneTouch Ping system will also work with the recently cleared ezManager(R) MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter- remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager(R) MAX software is MAC and PC compatible.

OneTouch Ping will be available for shipment in mid-August 2008. Customers can order at any time by calling 1-877-937-7867 or visit http://www.animascorp.com

About Animas Corporation

As part of the Johnson & Johnson Family of Companies, Animas is dedicated to creating a world without limits for people with diabetes through a wide range of products, including the Animas 2020 insulin pump, Inset 30 infusion set, ezManager MAX software and the new OneTouch Ping glucose management system. Animas, from the Latin word meaning true inner self or soul, has been committed since 1996 to individual patient needs through the development of life-performance technology and unparalleled customer service live 24 hours a day, 7 days a week, 365 days a year.

To learn more about Animas and its products, visit http://www.animascorp.com.

About LifeScan, Inc.

LifeScan, Inc., a Johnson & Johnson company and the leading maker of blood glucose monitoring products in the U.S., is dedicated to creating a world without limits for people with diabetes. The company develops, manufactures and markets a wide range of glucose monitoring systems and software for use by people with diabetes and health care providers. Every day, more than 4.5 million people with diabetes rely on OneTouch(R) Brand Products to provide accurate glucose results and help them use this information to take action so they can stay healthy.

For healthcare professional resources, and information on diabetes care and LifeScan products and services, visit http://www.LifeScan.com.


'/>"/>
SOURCE Animas Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. OneTouch(R) Laugh & Learn Sweepstakes to Award Scholarships for Summer Camp Experiences to Children with Diabetes
2. Dietary adherence associated with better glucose control in children with type 1 diabetes
3. No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones
4. ARKRAY USA Nationally Launches GLUCOCARD(TM) X-METER Blood Glucose Monitoring System
5. Standard Glucose Test May Be Wrong One for Obese Children
6. Formula Puts Doctor, Patient Glucose Readings on Same Page
7. Scientists ID Gene Regulating Blood Glucose Levels
8. New WaveSense Presto(TM) and Pro(TM) Glucose Meters to Simplify Testing
9. Special supplement on self-monitoring of blood glucose in diabetes technology & therapeutics
10. Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics
11. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” Pate ... year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children ... those children. James saw firsthand the effect of the critical funding gap for research ...
(Date:1/19/2017)... ... January 19, 2017 , ... Connecticut Dermatology Group (CDG) ... a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background in ... “It is with considerable pleasure to welcome back Dr. Kim to the CDG team” ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... From a ... are released almost daily linking gut health to chronic disease, mental health and general ... Year ” as an important resolution to consider. , For one Charlottesville restaurant, good ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced ... to compete in the Boston Marathon on April 17. From first-time participants to ... marathon to join Team V and support the Foundation’s mission to declare victory over ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)...   Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to restore ... the Company,s operating results for 2016 and an outline ... Company described in its recent 10-K filing with the ... The Company,s contract laboratory completed its evaluation of NovaDerm®, ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: